Omeros (OMER) Return on Sales (2010 - 2026)
Omeros recorded quarterly Return on Sales of 0.0% in Q1 2026, up 67.07% quarter-over-quarter from 0.0% in Q1 2025, and little changed year-over-year from 0.0% in Q1 2025.
Omeros' Return on Sales history runs 14 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2020 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales came in at 0.0% for Q1 2026 at Omeros, up from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Dec 31, 2020 | -0.07% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.02% |
| Mar 31, 2020 | -0.01% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.01% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.09% |
| Jun 30, 2018 | -0.21% |
| Mar 31, 2018 | -0.19% |
| Dec 31, 2017 | -0.01% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | -0.01% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | -0.03% |
| Dec 31, 2015 | -0.03% |
| Sep 30, 2015 | -0.06% |
| Jun 30, 2015 | -0.05% |
| Mar 31, 2015 | -0.49% |
| Dec 31, 2014 | -1.17% |
| Sep 30, 2014 | -0.84% |
| Jun 30, 2014 | -4.03% |
| Mar 31, 2014 | -1.64% |
| Dec 31, 2013 | -0.82% |
| Sep 30, 2013 | -0.72% |
| Jun 30, 2013 | -0.98% |
| Mar 31, 2013 | -0.10% |
| Dec 31, 2012 | -0.05% |
| Sep 30, 2012 | -0.09% |
| Jun 30, 2012 | -0.06% |
| Mar 31, 2012 | -0.06% |
| Dec 31, 2011 | -0.09% |
| Sep 30, 2011 | -0.07% |
| Jun 30, 2011 | -0.05% |
| Mar 31, 2011 | -0.05% |
| Dec 31, 2010 | -0.09% |
| Sep 30, 2010 | -0.30% |
| Jun 30, 2010 | -0.16% |